Cargando…
How Do Donor-Recipient CMV Serostatus and Post-Hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
Background: This study evaluated CMV serostatus in donors and recipients of hematopoietic stem cell transplantation (HSCT) and its effects on CMV reactivation of patients and all aspects of CMV on HSCT outcomes. Materials and Methods: Seven hundred and five adult acute leukemia patients (AML=408 and...
Autores principales: | Vaezi, Mohammad, Kasaeian, Amir, Souri, Maryam, Soufiyan, Faeze, Shokri Boosjin, Amir, Setarehdan, Seyed Amin, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625470/ https://www.ncbi.nlm.nih.gov/pubmed/28989586 |
Ejemplares similares
-
ABO Incompatibility and Hematopoietic Stem Cell Transplantation Outcomes
por: Vaezi, Mohammad, et al.
Publicado: (2017) -
CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients
por: Jaskula, Emilia, et al.
Publicado: (2012) -
A Comparison of Dexamethasone Plus Vincristine versus Standard Regimen in Induction Therapy of Adult Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplantation
por: Vaezi, Mohammad, et al.
Publicado: (2022) -
2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022) -
Donor and recipient CMV serostatus and antigenemia after renal transplantation: An analysis of 486 patients
por: Hughes, David, et al.
Publicado: (2008)